CYTK logo

CYTK

Profile

Full Name

Cytokinetics, Incorporated

Ticker Symbol

CYTK

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 30, 2004

Indexes

Not included

Website

http://www.cytokinetics.com

Employees

498

Key Details

Price

$40.43(+0.25%)

Market cap

$4.79B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.47M(+145.34% YoY)

Annual EPS

-$5.26(+3.49% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$40.43
CYTK price is $40.43

30-Day Relative Volume

0.41
CYTK 30-day relative volume is 0.41

Price Performance

Price Most recent change

+0.25%
CYTK price was up +0.25% on Apr 25, 2025

Price YTD change

-14.05%
CYTK price is down -14.05% since January 1st

Price 1-year change

-37.61%
CYTK price is down -37.61% year-on-year

Price 3-year change

+10.77%
CYTK price is up +10.77% over the past 3 years

Price Range

Price All-time high

$110.25
CYTK price is currently -63.33% below its historical high of $110.25

Price 3-year low

$25.98
CYTK price is currently +55.62% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.79B
CYTK market capitalization is $4.79 billion

Market cap 3-year change

+53.27%
CYTK market capitalization is up +53.27% over the past 3 years

Market cap All-time high

$11.42B
CYTK market capitalization is currently -58.06% below its historical high of $11.42 billion

Market cap sector rank

88.73%
CYTK market capitalization is higher than 88.73% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+13.02%
CYTK shares outstanding is up +13.02% year-on-year

Shares Outstanding 3-Year Change

+38.37%
CYTK shares outstanding is up +38.37% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
CYTK beta is 0.83

200-day SMA

$50.04
CYTK price is currently -19.21% below its 200-day simple moving average

50-day SMA

$42.53
CYTK price is currently -4.94% below its 50-day simple moving average

RSI

51.03
CYTK 14-day relative strength index is 51.03

Volume

0.41
CYTK 30-day relative volume is 0.41

ATR

$2.24
CYTK average true range is $2.24

10-day Historical Volatility

45.81%
CYTK 10-day historical volatility is 45.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$18.47M
CYTK annual revenue is $18.47 million

Revenue Analysts estimate

$35.64M
CYTK annual revenue is currently -48.16% lower than the consensus analysts' forecast

Revenue 1-year change

+145.34%
CYTK annual revenue is up +145.34% year-on-year

Revenue Sector rank

33.22%
CYTK annual revenue is higher than 33.22% of companies in Healthcare sector

EPS

EPS

-$5.26
CYTK annual earnings per share is -$5.26

EPS Analysts estimate

-$5.64
CYTK annual earnings per share is currently -6.71% lower than the consensus analysts' forecast

EPS 1-year change

+3.49%
CYTK annual earnings per share is up +3.49% year-on-year

EPS Sector rank

18.36%
CYTK annual earnings per share is higher than 18.36% of companies in Healthcare sector

Profit

Gross profit

-$320.93M
CYTK annual gross profit is -$320.93 million

Gross margin

-1737.22%
CYTK annual gross profit margin is -1737.22%

Operating profit

-$536.25M
CYTK annual operating income is -$536.25 million

Operating margin

-2902.72%
CYTK annual operating profit margin is -2902.72%

Net income

-$589.53M
CYTK annual net profit is -$589.53 million

Net margin

-3191.11%
CYTK annual net profit margin is -3191.11%

Expenses

Total expenses

$554.72M
CYTK annual total expenses is $554.72 million

Operating expenses

$215.31M
CYTK annual total operating expenses is $215.31 million

Cost of goods sold

$339.41M
CYTK annual cost of goods sold is $339.41 million

Selling, general & administrative expenses

$215.31M
CYTK annual SGA is $215.31 million

Depreciation and amortization

$9.53M
CYTK annual depreciation & amortization is $9.53 million

Interest expense

$86.51M
CYTK annual interest expense is $86.51 million

Income tax

-
CYTK annual income tax value is unknown

EBIT & EBITDA

EBIT

-$503.01M
CYTK annual earnings before interest & taxes is -$503.01 million

EBITDA

-$493.48M
CYTK annual EBITDA is -$493.48 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.40B
CYTK annual total assets is $1.40 billion

Non current assets

$293.73M
CYTK annual long term assets is $293.73 million

Current assets

$1.11B
CYTK annual total current assets is $1.11 billion

Cash and cash equivalents

$94.86M
CYTK annual cash & cash equivalents is $94.86 million

Accounts receivable

$16.65M
CYTK annual accounts receivable is $16.65 million

Inventory

-
CYTK annual inventory value is unknown

Liabilities

Total liabilities

$1.54B
CYTK annual total liabilities is $1.54 billion

Long term liabilities

$1.36B
CYTK annual total long term liabilities is $1.36 billion

Current liabilities

$179.67M
CYTK annual total current liabilities is $179.67 million

Accounts payable

$20.37M
CYTK annual accounts payable is $20.37 million

Debt

Total debt

$788.68M
CYTK annual total debt is $788.68 million

Total debt 1-year change

+4.35%
CYTK annual total debt is up +4.35% year-on-year

Long term debt

$758.18M
CYTK annual long term debt is $758.18 million

Short term debt

$30.50M
CYTK annual short term debt is $30.50 million

Equity & Capital

Shareholders equity

-$135.37M
CYTK annual stockholders equity is -$135.37 million

Book value

-$135.37M
CYTK annual book value is -$135.37 million

Retained earnings

-$2.70B
CYTK annual retained earnings is -$2.70 billion

Working capital

$928.27M
CYTK annual working capital is $928.27 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$395.89M
CYTK annual cash flow from operations is -$395.89 million

Cash from operations 1-year change

+4.45%
CYTK annual cash flow from operations is up +4.45% year-on-year

Cash from investing

-$553.10M
CYTK annual cash flow from investing activities is -$553.10 million

Cash from investing 1-year change

-331.18%
CYTK annual cash flow from investing activities is down -331.18% year-on-year

Cash from financing

$930.61M
CYTK annual cash flow from financing activities is $930.61 million

Cash from financing 1-year change

+320.49%
CYTK annual cash flow from financing activities is up +320.49% year-on-year

CAPEX

CAPEX

$3.91M
CYTK annual capital expenditures is $3.91 million

CAPEX 1-year change

+175.85%
CYTK annual capital expenditures is up +175.85% year-on-year

Free Cash Flow

Free cash flow

-$399.80M
CYTK annual free cash flow is -$399.80 million

Free cash flow 1-year change

+3.84%
CYTK annual free cash flow is up +3.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-1737.22%
CYTK annual gross profit margin is -1737.22%

Operating margin

-2902.72%
CYTK annual operating profit margin is -2902.72%

Net margin

-3191.11%
CYTK annual net profit margin is -3191.11%

ROA & ROE

ROA

-52.97%
CYTK annual return on assets is -52.97%

ROE

435.49%
CYTK annual return on equity is 435.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CYTK price to earnings ratio value is unknown

PE ratio Sector rank

-
CYTK price to earnings ratio is unknown

PB Ratio

PB ratio

-35.36
CYTK price to book ratio is -35.36

PB ratio Sector rank

0.91%
CYTK price to book ratio is higher than 0.91% of companies in Healthcare sector

PS Ratio

PS ratio

259.14
CYTK price to sales ratio is 259.14

PS ratio Sector rank

96.49%
CYTK price to sales ratio is higher than 96.49% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.48B
CYTK enterprise value is $5.48 billion

Enterprise value Sector rank

88.66%
CYTK enterprise value is higher than 88.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-11.11
CYTK EV/EBITDA is -11.11

EV/EBITDA Sector rank

10.82%
CYTK EV/EBITDA is higher than 10.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.17
CYTK annual current ratio is 6.17

Quick ratio

-
CYTK annual quick ratio value is unknown

Leverage

Debt to equity

-4.85
CYTK annual debt to equity ratio is -4.85

Interest coverage ratio

-5.81
CYTK annual interest coverage ratio is -5.81

Risk & Stability

Piotroski F-Score

3
CYTK piotroski f-score is 3

Altman Z-Score

-1.21
CYTK altman z-score is -1.21

Analyst ratings

Recent major analysts updates

Apr 24, 25 Barclays
Overweight
Apr 21, 25 HC Wainwright & Co.
Buy
Apr 15, 25 HC Wainwright & Co.
Buy
Apr 15, 25 B of A Securities
Neutral
Apr 10, 25 JMP Securities
Market Outperform
Apr 8, 25 Needham
Buy
Apr 4, 25 HC Wainwright & Co.
Buy
Apr 3, 25 Citizens Capital Markets
Market Outperform
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 13, 25 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

BLCO logo
Bausch Lomb (BLCO)
IONS logo
Ionis Pharmaceuticals (IONS)
INSP logo
Inspire Medical Systems (INSP)
KRYS logo
Krystal Biotech (KRYS)
ELAN logo
Elanco Animal Health Incorporated (ELAN)
GRFS logo
Grifols SA (GRFS)
ALKS logo
Alkermes (ALKS)
AXSM logo
Axsome Therapeutics (AXSM)
ADMA logo
ADMA Biologics (ADMA)
  • What is the ticker symbol for Cytokinetics Incorporated?
  • Does Cytokinetics Incorporated pay dividends?
  • What sector is Cytokinetics Incorporated in?
  • What industry is Cytokinetics Incorporated in?
  • What country is Cytokinetics Incorporated based in?
  • When did Cytokinetics Incorporated go public?
  • Is Cytokinetics Incorporated in the S&P 500?
  • Is Cytokinetics Incorporated in the NASDAQ 100?
  • Is Cytokinetics Incorporated in the Dow Jones?
  • When was Cytokinetics Incorporated's last earnings report?
  • When does Cytokinetics Incorporated report earnings?
  • Should I buy Cytokinetics Incorporated stock now?

What is the ticker symbol for Cytokinetics Incorporated?

The ticker symbol for Cytokinetics Incorporated is NASDAQ:CYTK

Does Cytokinetics Incorporated pay dividends?

No, Cytokinetics Incorporated does not pay dividends

What sector is Cytokinetics Incorporated in?

Cytokinetics Incorporated is in the Healthcare sector

What industry is Cytokinetics Incorporated in?

Cytokinetics Incorporated is in the Biotechnology industry

What country is Cytokinetics Incorporated based in?

Cytokinetics Incorporated is headquartered in United States

When did Cytokinetics Incorporated go public?

Cytokinetics Incorporated's initial public offering (IPO) was on April 30, 2004

Is Cytokinetics Incorporated in the S&P 500?

No, Cytokinetics Incorporated is not included in the S&P 500 index

Is Cytokinetics Incorporated in the NASDAQ 100?

No, Cytokinetics Incorporated is not included in the NASDAQ 100 index

Is Cytokinetics Incorporated in the Dow Jones?

No, Cytokinetics Incorporated is not included in the Dow Jones index

When was Cytokinetics Incorporated's last earnings report?

Cytokinetics Incorporated's most recent earnings report was on Feb 27, 2025

When does Cytokinetics Incorporated report earnings?

The next expected earnings date for Cytokinetics Incorporated is May 8, 2025

Should I buy Cytokinetics Incorporated stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page